13
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Microalbuminuria in Essential Hypertension

Pages 753-767 | Published online: 03 Jul 2009

References

  • Weisstuch J M, Dworkin L D. Does essential hypertension cause end-stage renal disease?. Kidney Int 1992; 41(suppl 36)33–37
  • Mogensen C E. Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 1987; 31: 673–689
  • Rudberg S, Persson B, Dahlquist G. Increased glomerular filtration rate as a predictor of diabetic nephropathy — An 8-year prospective study. Kidney Int 1992; 41: 822–828
  • Forsblom C M, Groop P, Ekstrand A, Groop L C. Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration. Br Med J 1992; 305: 1051–1053
  • Marshall S M. Screening for microalbuminuria: which measurement?. Diabetic Med 1991; 8: 706–711
  • Hoegholm A, Bang L E, Kristensen K S, Nielsen J W, Holm J. Microalbuminuria in 411 untreated individuals with established hypertension, white coat hypertension and normotension. Hypertension 1994; 24: 101–105
  • Ellis D, Coonrod B A, Dorman J S, Kelsey S F, Becker D J, Avner E D, Orchard T J. Choice of urine sample predictive of microalbuminuria in patients with insulin-dependent diabetes mellitus. Am J Kidney Dis 1989; 13: 321–328
  • Mimran A, Ribstein J, DuCailar G, Halimi J M. Albuminuria in normals and essential hypertension. J Diab Complic 1994; 8: 150–156
  • Cerasola G, Cottone S, Mule G, Nardi E, Mangano M T, Andronico G, Contomo A, Vecchi M L, Gallione P, Renda F, Piazza G, Volpe V, Lisi A, Ferrara L, Panepinto N, Riccobene R. Microalbuminuria, renal dysfunction and cardiovascular complications in essential hypertension. J Hypertens 1996; 14: 915–920
  • Gould M M, Mohamed-Ali V, Goubet S A, Yudkin J S, Haines A P. Microalbuminuria : associations with height and sex in non-diabetic subjects. Br Med J 1993; 306: 240–242
  • Bianchi S, Bigazzi R, Baldari G, Campese V M. Microalbuminuria in patients with essential hypertension: effects of several anti-hypertensive drugs. Am J Med 1992; 93: 525–528
  • Bigazzi R, Bianchi S, Campese V M, Baldari G. Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension. Nephron 1992; 61: 94–97
  • Summerson J H, Bell R A, Konen J C. Racial differences in the prevalence of microalbuminuria in hypertension. Am J Kidney Dis 1995; 26: 577–579
  • Weir M R. Salt. intake and hypertensive renal injury in african-americans. A therapeutic perspective. Am J Hypertens 1995; 8: 635–644
  • Ljungman S. Microalbuminuria in essential hypertension. Am J Hypertens 1990; 3: 956–960
  • Halimi J M, Mimran A. Albuminuria in untreated patients with primary aldosteronism or essential hypertension. J Hypertens 1995; 13: 1801–1802
  • Anderson S, Rennke H G, Brenner B M. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986; 77: 1993–2000
  • Yoshioka T, Shiraga H, Yoshida Y, Fogo A, Click A D, Deen W M, Hoyer J R, Ichikawa I. “Intact nephrons” as the primary origin of proteinuria in chronic renal disease. Study in the rat model of subtotal nephrectomy. J Clin Invest 1988; 82: 1614–1623
  • Mimran A, Ribstein J. Hyperfiltration in lean essential hypertension. Contrib Nephrol. Karger, Basel 1996; 119: 98–102
  • Mimran A, Ribstein J, DuCailar G. Is microalbuminuria a marker of early intrarenal vascular damage in essential hypertension?. Hypertension 1994; 23: 878–883
  • Borch-Johnsen K, Kreiner S. Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. Br Med J 1987; 294: 1651–1654
  • Jones S L, Close C F, Mattock M B, Jarrett R J, Keen H, Viberti G C. Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria. Br Med J 1989; 298: 487–490
  • Jensen J S, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B. Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects. Clin Sci 1995; 88: 629–633
  • Yudkin J S, Forrest R D, Jackson C A. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet 1988; 2: 530–533
  • Samuelsson O, Wilhelmsen L, Elmfeldt D, Pennert K, Wedel H, Wikstrand J, Berglund G. Predictors of cardiovascular morbidity in treated hypertension: results from the primary preventive trial in Goteborg, Sweden. J Hypertens 1985; 3: 167–176
  • Bigazzi R, Bianchi S, Nenci R, Baldari D, Baldari G, Campese V M. Increased thickness of the carotid artery in patients with essential hypertension and microalbuminuria. J Hum Hypertens 1995; 9: 827–833
  • Bianchi S, Bigazzi R, Baldari G, Sgherri G, Campese V M. Diumal variations of blood pressure and microalbu@nuria in essential hypertension. Am J Hypertens 1994; 7: 23–29
  • Bianchi S, Bigazzi R, Quinones Galvan A, Muscelli E, Baldari G, Pecori N, Ciociaro D, Ferrannini E, Natali A. Insulin resistance in microalbuminuric hypertension. Hypertension 1995; 26: 789–795
  • Weir M R, Dengel D R, Behrens M T, Goldberg A P. Salt-induced increases in systolic blood pressure affect renal hemodynamics and proteinuria. Hypertension 1995; 25: 1339–1344
  • Pedrinelli R, Giampetro O, Carmassi F, Melillo E, Dell'Ormo G, Catapano G, Matteucci E, Talarico L, Morale M, De Negri F, Di Bello V. Lancet 1994; 344: 14–18
  • Taddei S, Virdis A, Mattei P, Ghiadoni L, Sudano I, Arrighi P, Salvetti A. Lack of correlation between microalbuminuria and endothelial function in essential hypertensive patients. J Hypertens 1995; 13: 1003–1008
  • Schmieder R E, Veelken, Gatzka C D, Rûddel H, Schächinger H. Predictors for hypertensive nephropathy: results of a 6-year follow-up study in essential hypertension. J Hypertens 1994; 13: 357–365
  • Halimi J M, Ribstein J, DuCailar G, Ennouchi J M, Mimran A. Albuminuria predicts renal functional outcome after intervention in atheromatous renovascular disease. J Hypertens 1995; 13: 1335–1342
  • Schmieder R E, Ruddel H, Schlebusch H, Rockstroh J, Schächinger H, Schulte W. Impact of antihypertensive therapy with Isradipine and Metoprolol on early markers of hypertensive nephropathy. Am J Hypertens 1992; 5: 318–321
  • Reams G P, Lau A, Hamory A, Bauer J H. Amlodipine corrects renal abnormalities encountered in the hypertensive state?. Am J Kidney Dis 1987; 10: 446–451
  • Reams G P, Hamory A, Lau A, Bauer J H. Effect of nifedipine on renal function in patients with essential hypertension. Hypertension 1988; 11: 452–456
  • Erley C M, Haefele U, Heyne N, Braun N, Risler T. Microalbuminuria in essential hypertension. Reduction by different antihypertensive drugs. Hypertension 1993; 21: 810–815
  • Ljungman S, Wikstrand J, Hartford M, Aurell M, Lindstedt G, Berglund G. Effects of long-term treatment and aging on renal function and and albumin excretion in primary hypertension. Am J Hypertens 1993; 6: 554–563

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.